J7605
J7605 – Arformoterol, inhalation solution, fda approved final product, non-compo · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 40 NDCs crosswalked per 15 mcg $0.742/unit ASP+6%
📋 J7605 summary
J7605 is a HCPCS Level II J-code used to bill Arformoterol, inhalation solution, fda approved final product, non-compounded, administere..., billed per 15 mcg. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J7605: Arformoterol Tartrate, Arformoterol Tartrate Inhalation, Arformoterol Tartrate Inhalation Solution
Code J7605
Billing unit 15 mcg Payment limit $0.742/unit NDC-Crosswalk 40
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ7605
DescriptorArformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
Billing unit15 mcg
Payment limit / unit$0.742
Est. ASP / unit$0.700 est.
Mapped NDCs40
Data periodQ3 2026
Last updated2026-08-20
💊 About Arformoterol Oral Inhalation DRUG GUIDE
Arformoterol tartrate inhalation solution is used for the long-term, twice-daily maintenance treatment of bronchoconstriction (airway narrowing) in adults with COPD, including chronic bronchitis and emphysema.It is not a rescue inhaler and should not be used for sudden breathing attacks or acute flare-ups of COPD.
It is also not approved to treat asthma.
Clinical overview from our editorial drug guide for Arformoterol Oral Inhalation. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.742
Est. ASP / unit
$0.700 est.
Est. after 2% sequester
$0.727
HCPCS dosage
15 mcg
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionArformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
CoverageC — Carrier/MAC judgment
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2D1G
ASC payment group—
Action codeN — No maintenance this year
Effective date2008-01-01
Date added2008-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J7605 = 15 mcg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J7605 LEAST EXPENSIVE FIRST
40 NDCs map to J7605. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.742/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 42571-0464-73 | Arformoterol Tartrate 15 ug/2mL SOLUTION | Micro | 30 POUCH in 1 CARTON (42571-464-73) / 1 V... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS ASP |
| 43598-0777-30 | arformoterol tartrate 15 ug/2mL SOLUTION | Dr. | 30 POUCH in 1 CARTON (43598-777-30) / 1 V... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS + PDAC |
| 50742-0395-30 | Arformoterol Tartrate 15 ug/2mL SOLUTION | Ingenus | 6 POUCH in 1 CARTON (50742-395-30) / 5 VI... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS + PDAC |
| 60687-0770-83 | Arformoterol Tartrate 15 ug/2mL SOLUTION | American | 30 POUCH in 1 CARTON (60687-770-83) / 1 V... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS ASP |
| 62332-0633-30 | Arformoterol tartrate 15 ug/2mL SOLUTION | Alembic | 30 POUCH in 1 CARTON (62332-633-30) / 1 V... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS + PDAC |
| 69097-0168-53 | arformoterol tartrate 15 ug/2mL SOLUTION | Cipla | 30 POUCH in 1 CARTON (69097-168-53) / 1 V... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS + PDAC |
| 69097-0168-87 | arformoterol tartrate 15 ug/2mL SOLUTION | Cipla | 6 POUCH in 1 CARTON (69097-168-87) / 5 VI... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS + PDAC |
| 70436-0151-57 | Arformoterol Tartrate Inhalation 15 ug/2mL SOLUTION | Slate | 30 POUCH in 1 CARTON (70436-151-57) / 1 V... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS + PDAC |
| 70748-0175-30 | Arformoterol tartrate 15 ug/2mL SOLUTION | Lupin | 30 POUCH in 1 CARTON (70748-175-30) / 1 V... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS + PDAC |
| 70756-0612-70 | arformoterol tartrate 15 ug/2mL SOLUTION | Lifestar | 30 POUCH in 1 CARTON (70756-612-70) / 1 V... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS + PDAC |
| 72266-0259-30 | Arformoterol tartrate 15 ug/2mL SOLUTION | Fosun | 30 POUCH in 1 CARTON (72266-259-30) / 1 V... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS + PDAC |
| 72603-0208-30 | arformoterol tartrate 15 ug/2mL SOLUTION | NorthStar | 30 POUCH in 1 CARTON (72603-208-30) / 1 V... | 15 ug/2mL | 30 | $22.26 | $0.615 | ● Active | CMS + PDAC |
| 73043-0052-93 | Arformoterol Tartrate Inhalation 15 ug/2mL SOLUTION | Devatis, | 30 POUCH in 1 CARTON (73043-052-93) / 1 V... | 15 ug/2mL | 0.5 | $0.37 | $0.615 | ● Active | PDAC |
| 62756-0277-02 | Arformoterol Tartrate 15 ug/2mL SOLUTION | Sun | 6 POUCH in 1 CARTON (62756-277-02) / 5 VI... | 15 ug/2mL | 0.5 | $0.37 | $0.615 | ● Active | PDAC |
| 43598-0777-60 | arformoterol tartrate 15 ug/2mL SOLUTION | Dr. | 15 POUCH in 1 CARTON (43598-777-60) / 4 V... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS + PDAC |
| 50742-0395-60 | Arformoterol Tartrate 15 ug/2mL SOLUTION | Ingenus | 12 POUCH in 1 CARTON (50742-395-60) / 5 V... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS + PDAC |
| 60687-0770-84 | Arformoterol Tartrate 15 ug/2mL SOLUTION | American | 60 POUCH in 1 CARTON (60687-770-84) / 1 V... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS ASP |
| 62332-0633-60 | Arformoterol tartrate 15 ug/2mL SOLUTION | Alembic | 60 POUCH in 1 CARTON (62332-633-60) / 4 V... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS + PDAC |
| 69097-0168-64 | arformoterol tartrate 15 ug/2mL SOLUTION | Cipla | 12 POUCH in 1 CARTON (69097-168-64) / 5 V... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS + PDAC |
| 70436-0151-58 | Arformoterol Tartrate Inhalation 15 ug/2mL SOLUTION | Slate | 15 POUCH in 1 CARTON (70436-151-58) / 4 V... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS + PDAC |
| 70748-0175-60 | Arformoterol tartrate 15 ug/2mL SOLUTION | Lupin | 60 POUCH in 1 CARTON (70748-175-60) / 1 V... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS + PDAC |
| 70756-0612-60 | arformoterol tartrate 15 ug/2mL SOLUTION | Lifestar | 60 POUCH in 1 CARTON (70756-612-60) / 4 V... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS + PDAC |
| 72266-0259-60 | Arformoterol tartrate 15 ug/2mL SOLUTION | Fosun | 15 POUCH in 1 CARTON (72266-259-60) / 4 V... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS + PDAC |
| 72603-0208-60 | arformoterol tartrate 15 ug/2mL SOLUTION | NorthStar | 60 POUCH in 1 CARTON (72603-208-60) / 4 V... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS + PDAC |
| 76204-0026-02 | Arformoterol Tartrate Inhalation Solution 15 ug/2mL SOLUTION | Ritedose | 60 POUCH in 1 CARTON (76204-026-02) / 1 A... | 15 ug/2mL | 60 | $44.52 | $0.643 | ● Active | CMS + PDAC |
| 73043-0052-60 | Arformoterol Tartrate Inhalation 15 ug/2mL SOLUTION | Devatis, | 60 POUCH in 1 CARTON (73043-052-60) / 4 V... | 15 ug/2mL | 0.5 | $0.37 | $0.643 | ● Active | PDAC |
| 62756-0277-03 | Arformoterol Tartrate 15 ug/2mL SOLUTION | Sun | 12 POUCH in 1 CARTON (62756-277-03) / 5 V... | 15 ug/2mL | 0.5 | $0.37 | $0.643 | ● Active | PDAC |
| 27437-0055-30 | Brovana | Lupin | — | — | 30 | $22.26 | — | — | CMS + PDAC |
| 27437-0055-60 | Brovana | Lupin | — | — | 60 | $44.52 | — | — | CMS + PDAC |
| 27437-0060-30 | Brovana | Lupin | — | — | 30 | $22.26 | — | — | CMS + PDAC |
| 27437-0060-60 | Brovana | Lupin | — | — | 60 | $44.52 | — | — | CMS + PDAC |
| 76204-0026-01 | Arformoterol Tartrate Inhalation Solution 15 ug/2mL SOLUTION | Ritedose | 30 POUCH in 1 CARTON (76204-026-01) / 1 A... | 15 ug/2mL | 0.5 | $0.37 | — | ● Active | PDAC |
| 00093-5955-06 | ARFORMOTEROL TARTRATE 15 MCG/2 ML | Unknown | — | — | 0.5 | $0.37 | — | — | PDAC |
| 00093-5955-56 | ARFORMOTEROL TARTRATE 15 MCG/2 ML | Unknown | — | — | 0.5 | $0.37 | — | — | PDAC |
| 68462-0833-65 | ARFORMOTEROL TARTRATE (60X2ML,PF,LATEX-FREE) 15 MCG/2 ML | Unknown | — | — | 0.5 | $0.37 | — | — | PDAC |
| 68462-0833-35 | ARFORMOTEROL TARTRATE (30X2ML,PF,LATEX-FREE) 15 MCG/2 ML | Unknown | — | — | 0.5 | $0.37 | — | — | PDAC |
| 70748-0257-30 | ARFORMOTEROL TARTRATE (30X2ML) 15 MCG/2 ML | Unknown | — | — | 0.5 | $0.37 | — | — | PDAC |
| 70748-0257-60 | ARFORMOTEROL TARTRATE (60X2ML) 15 MCG/2 ML | Unknown | — | — | 0.5 | $0.37 | — | — | PDAC |
| 63402-0911-64 | BROVANA (60X2ML) 15 MCG/2 ML | Unknown | — | — | 0.5 | $0.37 | — | — | PDAC |
| 63402-0911-30 | BROVANA 15 MCG/2 ML | Unknown | — | — | 0.5 | $0.37 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$1.64M
Claims
38,654
Beneficiaries
19,106
Spend / beneficiary
$85.74
Spend / claim
$42.38
Trend by period
Where J7605 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #338 of 824
#333
THERAMEND, PER SQ CM... Q4342
$1.75M
#334
IPRATROPIUM-ALBUTERO... J7620
$1.75M
#335
LEUPROLIDE DEPOT* J1954
$1.75M
#336
CINQAIR J2786
$1.66M
#337
ONTRUZANT Q5112
$1.65M
#338
ARFORMOTEROL TARTRAT... J7605
$1.64M
#339
CELLCEPT* J7517
$1.62M
#340
CORTROPHIN J0802
$1.6M
#341
AZACITIDINE* J9025
$1.58M
#342
BETHKIS* J7682
$1.58M
#343
EVEROLIMUS* J7527
$1.54M
Total claims — #64 of 824
#59
IZERVAY J2782
41,264
#60
GAMMAKED* J1561
40,877
#61
XOLAIR J2357
40,450
#62
SODIUM CHLORIDE(J704... J7040
40,325
#63
LEQVIO J1306
38,806
#64
ARFORMOTEROL TARTRAT... J7605
38,654
#65
SIMPONI ARIA J1602
38,495
#66
IHEEZO J2403
37,882
#67
OPDIVO J9299
37,629
#68
FLUOROURACIL J9190
37,237
#69
ORTHOVISC J7324
37,232
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $1.64M | 19,106 | 38,654 | $85.74 | $42.38 |
| 2025 (Q1-Q4) | $8.52M | 31,780 | 191,893 | $268.21 | $44.42 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$8.66M
Medicare paid
$6.39M
Submitted services
11,974,171
Denial rate
3.4%
Allowed / service
$0.75
Submitted charges
$219.58M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
📊 What bills under J7605
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
40 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J7605 billing FAQ
What is HCPCS code J7605?
J7605 is a HCPCS Level II J-code used to bill Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J7605?
One unit of J7605 represents 15 mcg. Report the number of units equal to the dose administered divided by 15 mcg.
How many units of J7605 should I bill?
Divide the dose administered by the code's unit size (15 mcg) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J7605?
The Medicare Part B payment limit is $0.742 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.727 per unit. Payment limits are revised quarterly.
Which NDCs bill under J7605?
40 NDCs currently map to J7605 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J7605 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.